Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.

García-Pagán JC, Feu F, Bosch J, Rodés J.

Ann Intern Med. 1991 May 15;114(10):869-73.

PMID:
2014947
2.

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

Garcia-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J.

Hepatology. 1990 Feb;11(2):230-8.

PMID:
2307401
3.

Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.

Morillas RM, Planas R, Cabré E, Galán A, Quer JC, Feu F, García Pagán JC, Bosch J, Gassull MA.

Hepatology. 1994 Dec;20(6):1502-8.

PMID:
7982651
4.
5.

Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.

García-Pagán JC, Escorsell A, Feu F, Bandi JC, Moitinho E, Casado M, Bosch J, Rodés J.

J Hepatol. 1996 Apr;24(4):430-5.

PMID:
8738729
6.

Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.

Escorsell A, Feu F, Bordas JM, García-Pagán JC, Luca A, Bosch J, Rodés J.

J Hepatol. 1996 Apr;24(4):423-9.

PMID:
8738728
7.
8.

Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis.

Merkel C, Sacerdoti D, Bolognesi M, Buonamico P, Sticca A, Amodio P, Angeli P, Micotti L, Gatta A.

Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1221-5.

PMID:
10563530
9.

Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.

Albillos A, García-Pagán JC, Iborra J, Bandi JC, Cacho G, Pérez-Paramo M, Escorsell A, Calleja JL, Escartín P, Bosch J.

Gastroenterology. 1998 Jul;115(1):116-23.

PMID:
9649466
10.

Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.

Vorobioff J, Picabea E, Gamen M, Villavicencio R, Bordato J, Bessone F, Tanno H, Palazzi J, Sarano H, Pozzoli L, et al.

Hepatology. 1993 Sep;18(3):477-84.

PMID:
8359793
11.

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.

García-Pagán JC, Feu F, Navasa M, Bru C, Ruiz del Arbol L, Bosch J, Rodés J.

J Hepatol. 1990 Sep;11(2):189-95.

PMID:
2123914
12.

Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.

Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodés J, Bosch J.

Hepatology. 2003 Apr;37(4):902-8.

PMID:
12668985
14.

[Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].

Castaño G, Viudez P, Sookoian S, Carlevaro O, Riccitelli M, Frider B.

Gastroenterol Hepatol. 2000 Jun-Jul;23(6):275-81. Spanish.

PMID:
15324622
15.

Effects of 5-isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis.

Silva G, Segovia R, Ponce R, Backhouse C, Palma M, Roblero JP, Abadal J, Quijada C, Troncoso M, Iturriaga H.

Hepatogastroenterology. 2002 Sep-Oct;49(47):1357-62.

PMID:
12239942
16.

Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.

Tsai YT, Lee FY, Lin HC, Chang TT, Lay CS, Wang SS, Kong CW, Lee SD, Lo KJ.

Hepatology. 1989 Sep;10(3):283-7.

PMID:
2759546
17.

The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.

Grose RD, Plevris JN, Redhead DN, Bouchier IA, Hayes PC.

J Hepatol. 1994 Apr;20(4):542-7.

PMID:
8051395
18.

Effects of propranolol or propranolol plus isosorbide-5-mononitrate on variceal pressure in schistosomiasis.

Kong DR, Ma C, Wang M, Wang JG, Chen C, Zhang L, Hao JH, Li P, Xu JM.

World J Gastroenterol. 2013 Jul 14;19(26):4228-33. doi: 10.3748/wjg.v19.i26.4228.

19.

Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.

Mols P, Hallemans R, Melot C, Lejeune P, Naeije R.

J Hepatol. 1989 May;8(3):316-24.

PMID:
2732445
20.

Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.

Feu F, Bordas JM, Luca A, García-Pagán JC, Escorsell A, Bosch J, Rodés J.

Hepatology. 1993 Nov;18(5):1082-9.

PMID:
8225212

Supplemental Content

Support Center